Table 1 Baseline characteristics of 205 patients stratified by a 2-hour OGTT

Patients, n (%)

85 (41)

70 (34)

38 (19)

12 (6)

Age (years)

60 ± 12

60 ± 13

65 ± 11

63 ± 8

NS

Follow-up (years)

10 ± 3

10 ± 3

10 ± 4

11 ± 2

NS

Men, n (%)

72 (85)

59 (84)

23 (61)

10 (83)

0.04

STEMI, n (%)

50 (59)

43 (61)

22 (58)

8 (67)

NS

SBP (mmHg)

139 ± 27

136 ± 26

143 ± 30

119 ± 25

NS

DBP (mmHg)

86 ± 20

84 ± 18

81 ± 16

76 ± 19

NS

BMI (g/m²)

26 ± 5

27 ± 4

26 ± 5

28 ± 5

NS

Current Smoker, n (%)

47 (55)

46 (66)

20 (53)

5 (42)

NS

 ASA, n (%)

12 (14)

8 (11)

5 (13)

2 (18)

NS

 Statins, n (%)

66 (78)

60 (86)

32 (84)

10 (83)

NS

 Biguanides, n (%)

0 (0)

0 (0)

0 (0)

3 (27)

N/A

 Insulin, n (%)

0 (0)

0 (0)

0 (0)

4 (36)

N/A

 HbA1c (%)

5.5 ± 0.3

5.6 ± 0.4

6.0 ± 1.2

7.6 ± 1.4

<  0.001

 Fasting glucose (mmol/l)

4.7 ± 0,5

5.1 ± 0.6

6.2 ± 1.9

N/A

<  0.001

 2-hour glucose (mmol/l)

6.3 ± 1.1

8.6 ± 1.0

11.7 ± 2.9

N/A

<  0.001

 LDL (mmol/L)

3.1 ± 1.0

2.8 ± 0.8

2.5 ± 0.8

2.4 ± 0.6

0.01

 HDL (mmol/L)

1.2 ± 0.4

1.1 ± 0.3

1.1 ± 0.4

1.1 ± 0.3

NS

 Total cholesterol (mmol/L)

5.0 ± 1.2

4.7 ± 1.0

4.3 ± 1.0

4.0 ± 0.8

0.01

 Triglyceride (mmol/L)

1.5 ± 0.9

1.6 ± 1.0

1.5 ± 0.8

1.3 ± 0.6

NS

 LVM (g/m²)

102 ± 36

111 ± 42

123 ± 61

138 ± 56

0.02

 LVH, n (%)

21 (25)

26 (37)

16 (42)

8 (67)

0.01

 IVS (cm)

1.0 ± 0.2

1.1 ± 0.3

1.1 ± 0.3

1.2 ± 0.3

0.03

 LVID (cm)

4.9 ± 0.7

5.0 ± 0.9

5.0 ± 0.8

5.1 ± 0.4

NS

 LVPW (cm)

1.1 ± 0.3

1.1 ± 0.3

1.1 ± 0.3

1.2 ± 0.2

NS

 LVEF (%)

52 ± 11

51 ± 12

50 ± 12

54 ± 8

NS

 E/A ratio

1.2 ± 0.5

1.2 ± 0.7

1.0 ± 0.4

1.5 ± 1.4

NS